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THE USEFULNESS  OF DIFFUSION- EVALUATION WEIGHTED IMAGING IN 
CHOLESTEATOMA  DIAGNOSIS AND POSTOPERATIVE PATHOLOGIC 
CORRELATION 
 
 ABSTRACT  
 
   INTRODUCTION  
 
 Middle ear cholesteatomas consist of ectopic keratinized epithelial tissue that grows inside the mucosa-lined 
middle ear cavity and desquamates, accumulating keratin and epithelial debris leads to bone erosion. Bony 
erosion can result in destruction of the ossicles, creating conductive hearing loss, labyrinthine fistulas with 
sensorineural hearing loss and vertigo, facial nerve canal erosion and facial paralysis, and rare intracranial 
complications, such as meningitis and abscess  
 Diffusion-weighted imaging is a technique that measures the molecular diffusion of water (Brownian 
motion) within the tissues, which can be quantified using Apparent Diffusion co-efficient (ADC) 
 
  AIM 
      To evaluate the usefulness of DWI  in diagnosing middle ear cholesteatomas and to differentiate post 
operative inflammatory changes from  recurrent  cholesteatoma with the aid of postoperative pathological 
correlation 
 
 
OBJECTIVES  
1. To determine the usefulness of  diffusion restriction in differentiating middle ear focal lesions 
2. To determine the usefulness of newer diffusion techniques to detect smaller lesions and in 
postoperative recurrent lesions 
  
MATERIALS AND METHODS 
                       
     Forty patients between 10-60 YEARS  of either sex with suspected cholesteatoma both new and 
postoperative cases will be included in this study after approval of local ethical committee and obtaining 
informed consent.  
 
    Sequences used 
Using 3 tesla MRI scanner following sequences are used 
                        TI AXIAL AND CORONAL  
                         FST2 AXIAL AND CORONAL 
                         DWI AXIAL& CORONAL 
                         STIR 
 
  
  
 
RESULTS 
From the study it is concluded that  DW MRI  has  100%  sensitivity, 75 % specificity , 97.3% PPV and  
100% NPV in detecting cholesteatoma. Hence the MRI  is more accurate than  HRCT  in diagnosing  
cholesteatomas 
 
CONCLUSION  
Diffusion-weighted imaging is highly specific due to the high keratin content of cholesteatomas.Newer 
techniques allow detection of smaller lesions and may be sufficient to replace second-look surgery in patients 
with prior cholesteatoma resection .Thus early detection avoids unnecessary complications and can avoid 
second  looking surgery. DWI is superior to conventional T2  sequence  in detecting the cholesteatomas. 
HRCT and MRI are complementary to each other in diagnosing cholesteatomas. In preoperative cases HRCT  
has high diagnostic accuracy and MRI is usually used to confirm the diagnosis  whereas in postoperative cases 
HRCT is highly non specific and MRI plays significant role in diagnosing cholesteatomas. 
KEYWORDS : Diffusion restriction , Apparent diffusion coefficient,  second look surgery 
INTRODUCTION 
A  cystic collection of keratinised  squamous epithelium  laid on a fibrous 
matrix predominantly involving middle ear cavity rarely involving external 
auditory canal is called as cholesteatoma . Also called as “pearl tumor,” 
“margaritoma,” or “keratoma.” 
DWI  is the MRI technique which is based on the  brownian movement of 
particles within the particular voxel. 
DWI finds its utility in detecting  cholesteatomas if middle ear is not clearly 
visualised by otoscopic examination and  when HRCT temporal bone findings 
found to be inconclusive. 
DWI is very useful in recurrent cholesteatoma followup  especially in 
postoperative cases where middle ear cavity is filled with soft tissue  and no 
bone /ossicular erosions detected on HRCT scan.  
By using modern techniques (non echoplanar imaging ) smaller lesions are 
accurately diagnosed  and so second look surgery is avoided in previously 
operated patients. 
Newer techniques avoids skull base and ghost artifacts with high  image 
resolution. 
 
 
ANATOMY  OF EAR 1 
EXTERNAL EAR 
 MIDDLE EAR 
 INTERNAL EAR 
 
EXTERNAL EAR 
Starts  from the pinna to the  tympanic membrane . Its length is  2.5 centimetres 
and diameter is  0.7 centimetres.  
It has S shaped and it  runs above downward and forward direction. 
 Ear canal is divided into two parts 
o OUTER 1/3  CARTILAGENOUS 
          Anterior and inferior wall  - cartilaginous. 
          Superior and  posterior wall  - fibrous. 
o INNER 2/3 BONY 
                   The bony part is much shorter in children. 
MIDDLE EAR 2 
Important Structures:                                                                                           
 Epitympanic recess 
 Tympanic cavity 
 Ossicles  
 Aditus ad antrum  
 Mastoid air cells 
—  
 
 
The boundaries of  middle ear are  
 Roof (tegmental wall):  Tegmen tympani separates the tympanic cavity 
from  middle cranial fossa.  
 Floor (jugular wall): A bony plate separates tympanic cavity from 
superior bulb of the internal jugular vein . 
 Lateral wall (membranous wall) : The tympanum . 
 Medial (labrinthine wall): Separates middle ear cavity  from  inner ear 
structures. This wall has important features, namely:  
 The promontory: Is formed by the first turn of the cochlea. 
 Tympanic plexus:  Is formed by fibres of the facial, and 
glossopharyngeal nerve. 
 Two openings: Fenestra vestibuli and fenestra cochleae. 
 Posterior(mastoid wall): Separates the cavity from the mastoid antrum 
air cells.  It has the following openings: 
 Aditus to the mastoid antrum or aditus ad antrum- mastoid 
antrum or air cells. 
 Pyramidal opening: For tendon of stapedius 
 Posterior chorda tympani canaliculus: Transmits the chorda 
tympani nerve. 
 Anterior(carotid wall) :Separates the cavity from the carotid canal, with 
its contained internal carotid artery.  It has two openings: 
 Communicating with tensor tympani muscle  
 Auditory tube (pharyngo tympanic or Eustachian tube) 
 
The ossicles 
 Malleus (hammer) 
 Incus (anvil) 
 Stapes (stirrup) 
The malleus 
 Manubrium  
 Neck 
 Head 
 Lateral process 
  
The incus 
 Short process 
 Long process 
 Lenticular process 
 Incudostapedial joint 
 
 
The stapes 
 Head 
 Neck 
 Anterior crus  
 Posterior crus  
 Footplate 
 
 
Ligaments of the ossicular chain 
 Superior malleal ligament 
 Anterior malleal ligament 
 Lateral malleal ligament 
 Posterior incudal ligament 
 Purpose of the ossicuar chain 
 Impedance matching 
 Protection 
The tensor tympani 
 Larger of the two tympanic muscles. 
 Tendon leaves the bony wall via the cochleariform process. 
 
 The stapedius 
The smaller of the two tympanic muscles. 
Tendon leaves the bony wall via the apex of the pyramidal eminence. 
 
The eustachian tube 
 35-38 mm long. 
 Oriented downward, forward, medially.  
 Cartilaginous portion - outer 2/3. 
 Osseous portion -  inner 1/3. 
 Isthmus. 
 Tensor palatini muscle. 
 Impedance matching of the middle ear 3 
 Acoustic resistance of air -  41.5 ohms. 
 Acoustic resistance of cochlear fluid - 161,000 ohms. 
 This represents a ratio of 3880:1. 
 Without the impedance matching capabilities of the middle ear, only 
1/10 of 1% of the energy of an incoming sound wave would make it 
into the cochlea--99.9% of the energy would be reflected at the 
boundary. 
Area advantage 
 The area of the tympanic membrane is 17 times that of the oval 
window. 
 As the area decreases, the pressure increases. 
  
ACOUSTIC REFLEX 
 Bilateral. 
 Occurs in response to sound intensities delivered to either ear at 80-90 
dB above threshold. 
INNER EAR 
 Bony labyrinth 
 Membranous_labyrinth 
 
 Bony labyrinth 
The bony labyrinth (or otic capsule) forms the outer wall of the inner ear.   It 
consists of three parts: 
 Cochlea 
 Semicircular canals 
  Vestibule 
They contain  perilymph, a clear fluid 
The vestibule includes:  
 Utricle  
 Saccule  
Receptors in the vestibule  responsible for  gravity and linear acceleration  
sensations. 
The semicircular canals has thin semicircular ducts within it which is 
responsible for angular acceleration. The semicircular canals are continous with 
perilymph filled regions  within the vestibule . 
The cochlea is a bony, snail  like structure  with two and half  turns that 
contains the cochlear duct. The sense of hearing is provided by receptors within 
the cochlear duct.   
 Membranous_labyrinth 
It contains endolymph. Its walls are lined with distributions of eighth cranial 
nerve. 
 It includes  the utricle and the saccule. 
 
 
 
 
 
 
CHOLESTEATOMA 4 
A sac of keratin collection lined by squamous epithelium that enlarges 
progressively   is called as cholesteatoma. 
 
Epidermoid cyst  and Cholesteatoma are histologically  similar. 
 
Cholesteatomas are of  2 types: 
       Congenital cholesteatoma : seen in 2% of cases. 
       Acquired cholesteatoma: seen in 98% of cases. 
 Primary -   no history of chronic middle ear infection. 
 Secondary -history of chronic middle ear infection. 
Rarely  external ear cholesteatomas are reported. 
Acquired cholesteatomas are common in  two sites 
 Middle ear  
 Mastoid 
 
Congenital cholesteatomas are seen in  
 Cerebellopontine angle 
 Calvarium 
 Suprasellar cistern 
Congenital Cholesteatoma 5 
 
Three criteria for  congenital cholesteatoma 
 Pearly white mass medial to the tympanum. 
 Normal tympanum. 
 No previous history of ear surgery,  ear perforation or otitis media. 
Three important sites 
 Middle ear cavity 
 Cerebropontine angle 
 Petrous  bone apex 
Commonly seen  in the anterior middle ear cavity or around the eustachian tube. 
Seen usually in age group of  6 months to 5 years. 
Staging of congenital cholesteatoma 6 (Derlacki and Clemis ): 
Divided  into 3 stages 
1. Disease involving petrous pyramid. 
2. Disease localised to the mastoid . 
3. Disease localised to the middle ear. 
 Potsic  staging 7: 
Stage 1 : Single quadrant involvement. Ear ossicles and mastoids are spared. 
Stage 2 : Multiple quadrant involvement. Ear ossicles and mastoids are spared. 
Stage 3 : Ear ossicles involved with  sparing the mastoids. 
Stage 4  : Mastoid involvement. 
Pearly white mass behind  the tympanic membrane 
 
Acquired Cholesteatoma 
Wittmaack  theory :  
Posterosuperior region of attic or pars tensa with invagination of tympanum 
leads to formation of retraction pockets which further leads cholesteatoma 
formation. 
Toss classification of  retraction pockets 8: 
1. Grade 1:  Retracted pars flaccida of tympanum . malleus neck  seen 
separately from the tympanic membrane. 
2. Grade 2: Retracted pars flaccida of tympanum covering the neck of the 
malleus. No erosion of scutum. 
3. Grade 3: Retracted pars flaccida of tympanum  with malleus neck contact and  
with  mild erosion of scutum. 
4. Grade 4: Grade 3 with  severe erosion of scutum or the outer attic wall  . 
 Ruedi's theory :  
Infection leads to proliferation of the basal cells of stratum 
germinatum and  forms  collections of  stratified  squamous 
epithelium.  
 Habermann  theory:  
           Through the perforation  in the tympanic membrane , epithelium from 
external ear canal protrudes into the mesotympanum and proliferates to form 
cholesteatoma 
 Other  theories 9:   
 Metaplastic change  in the  mucosa  of the middle ear. 
 
 Trauma leads  to implantation  of squamous epithelium into the 
mesotympanum 
 
 
Primary acquired cholesteatoma 10 
 
 Primary acquired cholesteatoma is due to  tympanic membrane retraction. 
Medial retraction of the pars flaccida progressively into the attic leads to 
cholesteatoma . Scutum is eroded gradually and a enlarging defect is formed in 
the epitympanum.The ear drum progressively retracts over the ear ossicles 
causing ossicular destruction.  It enters posteriorly into the mastoids . It also 
erodes  the lateral semicircular canal leading  to vertigo and deafness. 
            
                Another  type of primary acquired cholesteatoma forms if there is the 
retraction of  posterior quadrant of the tympanum  . The tympanic membrane  
attaches  to the incus then  retracts postero medially laying down squamous 
epithelium which surrounds the stapes and finally retracts into the sinus 
tympani. 
         This type exposes the  facial nerve and stapes destruction . Surgical 
eradication of these lesions are very  difficult so recurrence more common. 
 
Secondary acquired cholesteatoma 
Secondary acquired cholesteatomas is because of  an injury to the tympanic 
membrane. Causes include  
 Trauma. 
 Surgical injury to the drum. 
 A perforation (Posterior marginal perforation) caused by acute otitis 
media .  
Even tympanostomy tube insertion  could leads to cholesteatoma formation.  
 
 
 
  
Classification based on Location in the Tympanic Cavity: 
Middle ear cholesteatomas can be classified as the following: 
 
● “Pars flaccida cholesteatomas ” localised to the Prussak space . Due to 
chronic infection ,keratin collects  and sac   forms . 
Behind normal  tympanum -primary acquired type. 
Through a perforation of the tympanum - secondary acquired type. 
 
● “Pars tensa cholesteatomas” are located in the lower portion of the TM 
Commonly seen  in 
 Facial recess . 
 Sinus tympani of the tympanic cavity. 
 Mastoid region. 
 
Special Groups of Cholesteatomas 
● “Mural cholesteatomas”  -  “automastoidectomy lesion " are extensively seen 
in the mesotympanum or mastoid antrum .They  drain their contents into the 
external auditory meatus through tympanic perforation   and leave the emptysac 
behind. The cavity expands   because of the  enzymatic activity and look like  a 
mastoidectomy defect  with no  previous surgical history . 
 ● “EAC cholesteatomas” 11, occurs in older population  
            They are subdivided into  
 Idiopathic  - Floor of the EAC  is the commonest site and it is 
usually bilateral . 
 Secondary - Depending upon the inducing factor, its location can 
vary. 
Epitympanic (attic) cholesteatoma 
  
Cholesteatomas cause bony erosion by  the following mechanisms: 
 Pressure effects leads to   remodeling of bone . 
 Increased enzymatic activity leads to increased  osteoclastic activity, which 
further leads to  bone resorption aggressively . When it becomes infected this 
process lightens up causing severe bone erosions. 
  
EPIDEMOLOGY 
Peak incidence occurs in the second decade. 
Cholesteatoma affects all age groups from  infants upto extreme  old age. 
HISTORY AND ETYMOLOGY 12 
In 1683 Joseph Guichard Duverney described a middle ear  soft tissue lesion  
most likely cholesteatoma.  
In 1838, Johannes Muller, the German pathologist named it as   
“cholesteatoma” (Greek ; chole + stear =fat, oma =tumor) . This term is 
misnomer because it  is not a tumoural lesion and the lesion does not contain 
fat.  
 
 
 PATHOLOGY 
GROSS DESCRIPTION 13 
Pearly white  masses of different sizes with creamy granular material embedded on 
it. 
 
 
MICRO DESCRIPTION 14 
 Keratin debris. 
 Layers of stratified squamous epithelium  mixed  with granulation tissue . 
 Chronic inflammatory infiltrate admixed with foreign body giant cell granulomas, 
cholesterol clefts and hemosiderin. 
 No evidence of metaplasia or  dysplasia. 
 
  
 
SYMPTOMS 
 Conductive hearing loss 
o Ear discharge 
o Ear pain 
o Facial weakness 
o Vertigo 
 Dizziness: Relatively uncommon 
 Headaches  
 Bleeding from the ear 
 
COMPLICATIONS 
1. Labyrinthine fistula (perilymphatic fistula) 15 
2. Cochlear fistula: less common 
3. Labyrinthitis 
4. Facial nerve dysfunction 
5. Extension into internal acoustic meatus leading to deafness 
6. Meningitis 
7.  Cerebral abscess  
8. Petrous apicitis  
9. Sigmoid sinus thrombosis 
 
SIGNS OF UNSAFE PERFORATION OF TYMPANIC MEMBRANE 
ON OTOSCOPY 
 
 Tympanic membrane perforation usually posterior and superior.  
 Annulus of the tympanic membrane perforation.. 
 Pearly white mass behind ear drum. 
 Bone erosions. 
 Associated granulation tissue. 
 
  
 
DIAGNOSTIC IMAGING 
HRCT 16 
 Cholesteatomas  appear  as soft tissue attenuation  mass with bony erosions 
 Pars flaccida  
 Superior extension: most common. Involves prussak space and 
with  erosion  of  scutum and ear ossicles . 
 Inferior extension: commonly seen in children 
 
 Pars tensa 
 Posterosuperior : It displaces ear ossicles laterally 
LOOK FOR  
 
 EROSIONS OF THE 
 Scutum 
 Ossicles 
 Lateral semicircular canals 
 DEHISCENSE OF THE 
 Facial nerve canal 
 Tegment tympani 
 INTEGRITY OF THE 
 Epitympanum 
 Aditus ad antrum and mastoid antrum 
 Oval and round window 
Preoperative imaging is necessary for  
 Otoscopically hidden lesions  especially sinus tympani region . 
 Antrum and epitympanum involvement . 
 To look for congenital anatomic variations . 
 
HRCT is ideal only  when  the middle ear cavity is  aerated and with 
bony erosions, but it lacks specificity when only soft tissue is present. 
 
MAGNETIC RESONANCE IMAGING 17  
Diffusion-weighted imaging is superior to Conventional non-contrast MR 
imaging . 
 Recurrence or residual tumour are accurately diagnosed using DWI . If  DWI 
not restricted  "second look" surgery can be avoided .  
MRI is to look for 
 Dural invasion 
 Epidural abscess 
 Subdural abscess 
 Meningitis 
 Brain herniation into the mastoid 
  Facial nerve involvement 
 Thrombosis of venous sinuses especially sigmoid sinus 
 
 
 
SIGNAL INTENSITIES IN VARIOUS MR SEQUENCES 
 Cholesteatoma 
 T1: Hypointense 
 T2: Hyperintense 
 DWI:  Restriction  ( due to keratin) 
 T1 C+ (Gd): No enhancement  (avascular) 
 Cholesterol granuloma 
o T1: Hyperintense ( due to fat) 
o T2: Hyperintense 
o DWI:  No restriction 
o T1 C+ (Gd): No enhancement 
 Granulation tissue 
o T1: Heterointense 
o T2: Hyperintense 
o DWI:  No restriction 
o T1 C+ (Gd):  Delayed Enhancement ( poorly vascular) 
 Scarring 
o T1: Hypointense 
o T2: Hypointense  ( fibrous tissue) 
o DWI:  No restriction 
Gadolinium enhanced T1-weighted MRI can reliably distinguish granulation 
tissue and  residual cholesteatoma. Cholesteatomas are avascular so no 
enhancement .Granulation tissue is poorly vascularized  so it enhances on 
delayed images. 
DWI  is a specialized technique in MRI  that measures the molecular diffusion 
of water within the tissues, which can be quantified using Apparent Diffusion 
co-efficient (ADC) 
             B value  indicates  the degree of diffusion weighting applied.  
Higher  b values are  used to detect slow moving particles. 
ADC values  are  calculated using various  b-values . 
 ADC values less than 1.0 to 1.1 x  10-3 mm2/s  are considered significant. 
High keratin in cholesteatomas are responsible for diffusion restriction. 
High bone density of the inner ear  structures and numerous air-bone 
interfaces leads to various artifacts hindering  the diagnostic ability of DWI . 
Newer techniques  such as HASTE and  BLADE  allow detection of smaller 
lesions and may  replace second-look surgery in patients with prior 
cholesteatoma resection. Thus early detection avoids unnecessary 
complications and can avoid second  looking surgery. 
 DIFFERENTIAL DIAGNOSIS 18 
 Cholesterol granuloma 
 Granulation tissue 
 Scar 
 Cerumen: seen  in the external ear 
 Middle ear abscess: can show diffusion restriction but different clinical 
scenario . 
TREATMENT 19 
Eradication of cholesteatoma is mandatary but multiple surgeries may be 
required. 
The surgical removal has two objectives 
 Remove a progressive primary pathology . 
 Preservation of normal  hearing function. 
 
Removal of  involved ear ossicles is  mandatary  if  there is high probability of  
residual disease. 
 
Transcanal atticotomy approach with subsequent  tympanoplasty can be used 
for smaller lesions within  prussak space. 
Very low rate of recurrence of cholesteatomas seen in  Canal wall–down  
tympanomastoidectomy . 
Patients have traditionally undergone two -stage operations  
 First stage procedure  for eradication  of the primary pathology. 
 Second stage procedure  performed  6–18 months after the initial surgery 
to look  for residual /recurrent disease. 
 
Canal wall–down  tympanomastoidectomy helps in removal  of cholesteatoma 
in 3 ways : 
1. Adherent surface of the cholesteatoma is removed. 
2. Hidden cholesteatomas can be eliminated by removing the barrier. 
3. It provides the path for the surgical instruments to enter into middle ear 
cavity . 
 
 
Careful design and construction of the mastoid cavity,reconstruction of the ear 
canal wall,preservation of the auditory  canal wall and reconstruction of the 
chain of ossicles are essential to prevent recurrent disease.  
  
 
REVIEW OF LITERATURE 
 
  Jean-Philippe Vercruysse et al 20 states that  sensitivity, specificity, PPV 
and NPV for DWI is  81, 100, 100 and 40%, respectively for primary 
cholesteatomas  and for recurrent post operative cases DWI has the 
sensitivity, specificity, PPV and NPV of 12.5, 100, 100 and 72%, 
respectively. So it  concludes DWI is accurately able to detect large 
primary cholesteatoma  but inable to detect small residual  cholesteatoma 
<5mm. 
 
 Bert De Foer et al 21 proves  Single shot  turbo spin echo  DWI sequence 
has high sensitivity in detecting small cholesteatomas .Smallest size 
detected is 2 mm. In study of 21 patients  DWI can identify 19 of cases 
accurately. 
 Milan Profant et al 22 states pooled sensitivity of nonechoplanar diffusion 
weighted imaging for cholesteatoma detection is 96.15%, specificity was 
71.43%. Positive predictive value was 92.59%  and negative predictive 
value was 83.33% . In 25 out of 33 patients (both primary and recurrent 
cases)  DWI  accurately detects  the  cholesteatoma. 
 
 Anne Geoffray et al 23 states sensitivity to diagnose recurrent 
cholesteatoma was 87% for both DWI and delayed post-gadolinium 
sequences and the specificity was 71% and 83%, respectively . Adding 
both sequences, the sensitivity was 87%, the specificity increased to 
100%. DWI  is equally sensitive to  contrast enhanced MRI  in detecting 
recurrent cases . In 20 pediatric cases 18 are correctly diagnosed and it 
avoids the second looking surgery in recurrent cholesteatoma in children.  
Small recurrences less than 5 mm may be missed, so this study 
recommends  prolonged  follow-up for 5 years. 
 
 Mark C.J. Aarts  et al 24 states for the 8 EPI DWI studies, the pooled 
sensitivity was 68%, specificity was  87%, positive predictive value was 
81%, and negative predictive value  was 78 % For the 3 non-EPI DWI 
studies, the sensitivity was 97%, specificity was 97%, positive predictive 
value was 97%, and negative predictive value was 97 %. Non-EPI  is 
superior to EPI in detecting  cholesteatomas  as it avoids susceptibility  
artifacts and even detects smaller lesions. 
 
 In Stasolla, Alessandro et al 25 18 postoperative  cases suspected for 
having relapsing/residual cholesteatoma are subjected to DWI. In EPI-
DWI, 5 out of 6 patients with cholesteatoma showed diffusion restriction 
Noncholesteatomatous lesions  doesnot show diffusion restriction . The 
study has sensitivity of 86%, specificity of 100%, positive predictive 
value of 100%, and negative predictive value  of 92% in diagnosing 
relapsing/residual cholesteatomas . 
 
 S. Khemani  et  al 26 states  non-echo planar DWI is highly sensitive and 
specific for detecting recurrent cholesteatoma .HRCT ,conventional MRI 
and delayed contrast T1 are used in detecting postoperative 
cholesteatoma. Delayed contrast T1 is comparatively good  than  HRCT 
and conventional MRI. Sensitivities and specificities of all other MR 
sequences  and HRCT methods are low and  non echo planar DWI is 
proved to be superior to all other techniques. 
 
 In  S. Thiriata et al 27 cohort of 15 postoperative  patients were 
retrospectively studied. Diffusion-weighted images were obtained and the 
apparent diffusion coefficient values were calculated. Three specific  
ADC value ranges are obtained for three groups of lesions detected at 
surgery  (pure cholesteatoma, cholesteatoma with infection, and abscess 
or infection). Mean ADC values of  abscess /infection is found to be 
significantly  lower  than the cholesteatoma. 
 
 Amit Karandikar et al 28 states  in a  retrospective study  of 15 patients 
clinically confirmed or suspected cholesteatomas who underwent 
PROPELLER DWI, 13 patients had cholesteatomas while two patients 
had mastoid abscesses. "Average ADC values of cholesteatoma was 
0.868 × 10−3 mm2/s and ADC values for abscess is  0.425 × 10−3 mm2/s". 
 
 Migirov et al 29 states DWI  shows bright signal in 27 cases of primary 
and 23 cases of recurrent cholesteatoma with 98 %  clinical and 
radiological concordance . DWI overestimates the diagosis of recurrence 
in one case and smallest lesion detected is 3 mm. Lesion less than 8mm 
confined to middle ear are removed by endoscopic transcanal technique 
whereas larger lesions are removed by retroauricular  mastoidectomy. 
 
 Corrales et al  30 states HRCT and DWI are complementary to each other 
in diagnosing cholesteatoma. It proved that Non EPI  DWI is superior to 
EPI  and delayed contrast  gadolinium enhanced  MR images. 
 
 In Kodama  et al 31 cholesteatoma was accurately diagnosed by showing 
diffusion restriction on EPI-DWI and FASE sequence with sensitivity  of 
73.3% and 90%, respectively. Image distortion noted in EPI-DWI 
compared to FASE-DWI mainly  because of susceptibility artifacts in 
EPI. 
 
 P D Yates  et al 32 states the role of HRCT  in  diagnosing cholesteatoma 
and its extent  and involvement of  tegmen tympani, semicircular canals , 
ear ossicles  and facial nerve  canal involvement. However in absence of 
bony erosion diagnosis is difficult. 
 
 In M.Wake et al 33 pre-operative HRCT was performed prior to revision 
surgery in 10 patients  to check for cholesteatoma. Three independent 
radiologist reports  were obtained on the HRCT scans and compared with 
the peroperative findings. It  emphasise HRCT is not useful in the 
diagnosis of recurrent cholesteatoma. There was poor inter-observer 
agreement in interpretation of the HRCT temporal bone. 
 
  In  Dirk Vanden Abeele et al 34 18 patients were examined with MRI 
prior to revision surgery. It states that only 61% radiosurgical correlation 
and  at present MRI is not a very good alternative to revision surgery in 
recurrent cases . MRI not clearly delineates  small cholesteatoma from 
scar tissue.  
 
 Pisaneschi, Mark J., and Bradley Langer et al 35 explains the ability of 
MRI in differentiating congenital cholesteatoma and cholesterol 
granuloma of the temporal bone due to hyperintense signal of cholesterol 
granuloma in T1 images and cholesterol granuloma does not shows any 
diffusion restriction. 
 
 Joselito L. Gaurano,  Ismail A. Joharjy et al 36 states  the role of HRCT in 
detection of early erosive changes suggestive of cholesteatoma in study 
of 64 patients. however  MRI  is needed to confirm the diagnosis if there 
is no bone erosion. 
 
 K. Barath et al 37 states the role of conventional MR  imaging  (T1 ,T2  
and postcontrast T1 images) in differentiating other soft tissues from 
cholesteatomas  and  proves post contrast T1 is superior to conventional 
T2  images in diagnosing cholesteatomas. 
 
 In Venail et al 38 45 patients incuded in the study and it compares DW-
EPI with delayed Gadolinium enhanced  T1 MR imaging in postoperative 
patients. It confirms DWI has high specificity but less sensitivity 
compared to delayed Gadolinium enhanced  T1 MR imaging. Specificity 
was further  increased by combining these two techniques only for larger 
cholesteatomas  more than 5 mm but for small cholesteatomas there is no 
improved specificity. 
 
 In Pizzini et al 39 out of 30 patients HASTE DWI accurately detects all 
the cases with sensitivity ,specificity, PPV and NPV  of 100 %.  
 
 In Kasbekar et al  4019 patients are studied using PROPELLER 
DWIand it proves DWI  has  sensitivity of  57% , specificity of 75%, 
PPV 62% and NPV 75%. Kasbekar et al states if a low-resolution 
imaging matrix of 128 × 128 was used, smaller lesions can be missed . 
Higher signal noise ratio and less blurring are seen  in PROPELLER 
comparison with HASTE DWI. 
 
 In Lehman et al  41 35 patients are studied using PROPELLER DWI 
with sensitivity of  96.5% , specificity of 100%, PPV 100%, NPV 
96.3%. 
 
 In Dubrulle et al 42 24 patients are studied using multishot DWI with 
sensitivity of  100% , specificity of 91%, PPV 93% and  NPV 100 %. 
 
 Fernando Más-Estellés et al  43 states non EPI is superior to HRCT for 
accurately diagnosing cholesteatoma and detects small lesions  of size 
2mm  and avoids posterior fossa susceptibility artifacts. Out of 52 
patients studied using PROPELLER sequence with sensitivity 92.8% 
and specificity 92.3%.ADC values found to be 0.8–1.1 ×10-3mm2/sec 
ADC values found found in abscesses is 0.4–0.6 × 10-3mm2/sec and 
very high values found in cholesterol granulomas 2–3 × 10-3mm2/sec . 
The bright signal at  DWI on b = 0 sec/mm2 images that persists or 
increases on high b value (1000 sec/mm2) is characteristic of 
cholesteatoma . 
 
 In A. Turan Ilıca et al 44  17 cases are included in study both primary 
and recurrent lesions. HASTE DWI accurately detects  11 primary and 
5 postoperative cases . one small lesion 4mm is  missed . This study 
has the sensitivity of  94% , specificity of 100%, PPV 100%  and  NPV 
80%. 
 
 In Dhepnorraret  et al 45 22 patients are studied using multishot DWI 
with sensitivity of 100% , specificity of 100%, PPV of 100% and  
NPV 100%.  Smallest lesion detected is 3mm. 
 
 In Kimitsuki et al 46 19 patients were studied . It states that 
conventional MRI should not replace revision surgery  for recurrent 
cholesteatoma due to poor radiosurgical correlation in 30% of their 
patients .However, in this study  no diffusion MRI was used, and the 
Gadolinium enhanced images were  also not delayed. 
 
 "K.M. Schwartz J.I. Lane B.D. Bolster, Jr  and B.A. Neff" 47 states 
modern non EPI sequences used in DWI  though increases scanning 
time it avoids ghost artifacts , susceptibility artifacts, off resonance 
effects and geometrical distortion. However T2 blurring will be seen in 
DWI HASTE images and  it also proves  non EPI has high sensitivity 
and specificity in diagnosing cholesteatomas. 
 
 In K. Yamashita et al 48 30 clinically suspected  patients were operated 
and cholesteatoma was histopathologically proved  in all the cases. 30 
cases of cholesteatomas, 20 primary and 10 recurrent patients  were 
assessed by the observers. Excellent interobserver agreement was 
found for both MS-EPI (kappa values  0.856) and SS-EPI (kappa 
values 0.820). It proves MS-EPI has a higher sensitivity  and accuracy 
than SS-EPI.  
 4 cholesteatomas were not diagnosed  on both SS-EPI and MS-EPI. 
Even on retrospective observation, these lesions were  not able to 
identified on conventional MR sequences . 
 
 Schaefer et al 49 measured the ADC values of cholesteatoma which are 
identical to gray matter but lower than CSF. They showed  
combination of T2 shine through and restricted diffusion was 
responsible for the bright signal of cholesteatomas on DWI.  
 
 Chen et al 50 reported  a series of 8 patients with epidermoids and 
measured ADC values. They concluded that the hyperintensity of 
epidermoids on DWI  is only by T2 shine-through effects not by 
restricted diffusion .  Chen et al states the "mean ADC of epidermoids 
was found to be 1.197 × 10−3 mm2/s". T1, Fast T2, proton density 
weighted dual-echo sequences, Fast-FLAIR sequences, and DW EPI  
totally five sequences used and are compared. Echo-planar DW 
imaging is  better  than Fast FLAIR and other conventional sequences 
in detecting epidermoids. 
 
 Sharad Maheshwari and Suresh K. Mukherji 51 states the apparent 
diffusion coefficient values in the cholesteatoma were 0.58 x 10-3 
mm2/s..  The hyperintensity of cholesteatoma on DWI  is likely a 
combination of T2 shine through and restriction effects . 
 
 In Dalia Monir Fahmy and  Sameh M. Ragab 52  case study 20 patients 
(7 female and 13 male patients) were subjected to MR examination 
before surgery  DWI  combined with conventional MR sequences 
depicted 8 cholesteatomas. Two lesions were missed that were <3 mm. 
One patient was misdiagnosed as cholesteatoma, biopsy revealed acute 
inflammation. It has sensitivity of 80%, specificity of  90%, positive 
predictive value of  89% and negative predictive value of  82%.  
Granulation  tissue ADC ranged from 0.541 to 0.128 x 10-3 mm2/s 
(with a mean value of 0.33± 0.09),all showed moderate enhancement 
on post contrast study.  All eight cases of residual cholesteatoma 
showed high SI on DWI, ADC value ranged from 0.984 to 0. 563 x 10-
3mm2/s (with a mean value of 0.77 ± 0.13). Three cases showed no 
significant enhancement, while remaining five showed marginal 
enhancement. No overlap was found between ADC values of residual 
cholesteatoma and granulation tissue with a cut off value of 0.55 x  10-
3 mm2/s. 
 
 Poornima Digge et al 53 states  the limitation of HRCT  in diagnosing 
cholesteatomas .  In HRCT cholesteatomas appears  as non-dependent 
soft tissue density and bony erosions, which is also seen in cholesterol 
granuloma, ectopic meningioma and  middle ear effusion .HRCT scan 
correlated with the surgical finding and histopathologic reports with a 
high degree of accuracy for middle ear ossicular erosion (96.8%),for 
the incus erosion (96.4%) and (100%) for the malleus erosion. 
however  MRI is ideal in diagnosing recurrent  cholesteatoma . 
 
 Mosnier et al 54 operated on 50 patients with brain herniation and 
chronic otitis media: 14 of them (28%) were found to have an 
encephalocele that was the result of previous mastoid surgery. Their 
study findings confirmed that a CT scan is the procedure of choice for 
identifying tegmen erosion and when there is suspicion of an existing 
encephalocele, but that MRI is essential to differentiate between 
cholesteatoma, brain herniation and inflammatory tissue. 
 
 Elefante et al 55  recommends replacement of Single shot EPI with 
multishot  turbospin echo  in the MRI routine study of primary and 
recurrent middle ear cholesteatoma because of the increased diagnostic 
accuracy(0.97) and the lower NPV(1), with a substantial reduction of 
misdiagnosis. In the study of 32 patients, 16 patients were suspected of 
having primary cholesteatoma and 16 of having recurrent disease are 
subjected to MRI  interpreted by two unexperienced radiologists and 
two experienced neuroradiologists. Inter reader agreement between the 
observers revealed the superiority of multishot  turbospin echo  
compared to Single shot  EPI. Inter rater agreement among all the four 
observers was higher by using multishot  turbospin echo  compared to 
Single shot  EPI. 
 
 In P. Aikele et al 56 22 post operative patients were subjected to MR 
imaging.  DWI  with conventional MR imaging diagnosed 10 of 13 
cholesteatomas with sensitivity of 77%. 3 small lesions were missed . 
Specificity of MRI was 100%.The positive predictive value was  
100%.  and negative predictive value  was 75%. 
 
 In H. Sharifian et al 57  35 clinically  cholesteatoma suspected  patients 
were subjected to 3 MRI sequences including delayed post-
Gadolinium enhanced MRI, EPI and non-EPI-DW sequences and the 
MR findings were compared with postoperative findings. Two 
experienced radiologists analysed the images.. 26 cases of 
cholesteatoma detected at the surgery. Sensitivity and specificity of 
non EPI DWI is superior to EPI and  delayed post-Gadolinium 
enhanced MRI. Specificity of EPI DWI is only slightly higher than 
delayed post contrast images. 
 
 
 
 
Imaging sensitivity specificity  
Radiologist 1 2 Radiolo
gist 1 
2 
Delayed post-Gadolinium 
enhanced MRI 
73.1 % 84.6 77.8% 88.9  
EPI 61.5% 50 88.9% 88.9  
Non EPI 96.2% 92.3 100% 100  
 
 In Cimsit et al 58  26  patients with both primary and recurrent lesions 
were analysed with HRCT and MRI.  Loss of middle ear aeration on 
HRCT and signal changes on DWI were analysed .Histopathology was 
compared with image findings.  Out of  26 patients 14 were diagnosed 
as non cholesteatomatous lesion. 12 patients were diagnosed as 
recurrent cholesteatoma of which 11 were histopathologically 
confirmed. This study has PPV of 91.7% and NPV of 100 % . 
Associated granulation tissue noted in 4 patients which shows soft 
tissue more than diffusion restricted areas noted within the middle ear.  
It  confirms DWI can reliably distinguish cholesteatoma from other 
middle ear soft tissue lesions  and can be used in place of second look 
surgery 
 
  
 
 
AIM:  
                  To evaluate the usefulness of DWI  in diagnosing middle ear 
cholesteatomas and to differentiate post operative inflammatory changes from  
recurrent  cholesteatoma with the aid of postoperative pathological correlation 
 
  
OBJECTIVE: 
 
1. To determine the usefulness of  diffusion restriction in differentiating 
middle ear focal lesions 
2. To determine the usefulness of newer diffusion techniques to detect 
smaller lesions and in postoperative recurrent lesions 
 
 
 
 MATERIALS AND METHODS 
 
                      Forty patients between 10-60 years  of either sex  with suspected 
cholesteatoma both new and postoperative cases will be included in this study 
after approval of local ethical committee and obtaining informed consent.  
 Inclusion Criteria 
 10 – 60  years  of either sex in whom middle ear focal lesion suspected on 
otoscopic examination 
 In  patients whom HRCT temporal bone found to be inconclusive 
 Postoperative patients before second looking surgery 
 
Exclusion Criteria 
 Patients whom not given the consent. 
 Pregnant patients 
 Patients with  cochlear implant 
 Patient with MR  incompatible pacemaker 
 Other general contraindications for MRI 
 
Sequences used 
Using 3 tesla MRI scanner following sequences are used 
                        TI AXIAL AND CORONAL  
                         FST2 AXIAL AND CORONAL 
                         DWI AXIAL& CORONAL 
                         STIR 
DWI 
Patients  suspected  of  having middle ear focal lesions by otoscopic 
examination,postoperative patients ,HRCT temporal bone inconclusive patients 
are  subjected to different MRI sequences, DWI especially HASTE  axial 
images with  b-values of  0 and 1000 s/mm2.  
DW images obtained  and ADC maps were derived automatically from the 
software on  voxel-by-voxel basis.  
        The results are compared with the postoperative pathological findings and 
analysed using statistical package. 
 
 
 
CASE 1 
A 40 year male outpatient comes with left ear discharge and  mild deafness for 
past 6 months. 
Headache on and off  for 2 months duration. 
History  of  left middle ear surgery 10 years back  for the similar complaints 
cortical mastoidectomy done  and cholesteatoma removal  done. 
 
T1 AXIAL 
 
   
 
 
T1 CORONAL 
  
T2 AXIAL 
 
 
 
FLAIR CORONAL 
 
 
DWI 
  
 
ADC 
 
 
 
 
DISCUSSION  
Lesion noted in the left middle ear  has low signal on T1 images, high signal on 
T2  and FLAIR images  and showing diffusion restriction with corresponding 
low ADC values  - 0.59 x  10-3 mm2/s   and the provisional diagnosis of 
cholesteatoma was made . Patient was taken for surgery  and removal of middle 
ear mass done and specimen sent for histopathological analysis.HPE reveals and 
confirms the diagnosis of cholesteatoma. 
 
 CASE 2 
A 38 year old male comes with complaints of left middle ear hearing loss and 
ear discharge for past 4 months duration. 
History of cholesteatoma surgery 7 years back. 
Otoscopy reveals the lesion in the middle ear. 
CT shows soft tissue density lesion in left middle ear and patient is referred for 
MRI for suspicion of recurrent cholesteatoma . 
CT 
 
 
 
 T1  AXIAL  
 
T2 AXIAL 
 
 
DWI 
 
 
ADC 
  
 
DISCUSSION  
Lesion appears hyperintense both in T1 and T2 sequences and doesnot shows 
diffusion restriction with ADC value - 0.45x  10-3 mm2/s   and  diagnosis of 
granulation tissue was made  which was subsequently confirmed by 
postoperative histopathological analysis. 
CASE 3 
42 year old male patient  who has been operated twice for cholesteatoma   
comes with compliants of ear pain with discharge for past 6 months . 
First surgery in 2005 and second in 2009. 
Otoscopy suspicious for recurrent lesion. 
CT  shows soft tissue opacity in the right middle ear . 
T1 CORNAL 
  
T2 CORONAL 
 
 
DWI 
 
 
ADC 
 
 
 
DISCUSSION 
Lesion appears heterointense in T1 and hypertintense on T2 and shows 
diffusion restriction significantly with low  ADC values - 0.62x10-3 mm2/s   and 
the diagnosis of cholesteatoma was made . 
Postoperative histopathological report confirms the MRI  finding. 
Heterogenicity  of the lesion in T1  is commonly seen in recurrent 
cholesteatoma. 
 
 CASE 4 
50  year old male patient  comes with compliants of left ear pain  and ear 
discharge for past 10months. 
Otoscopy reveals pearly white mass behind the tympanum. 
CT shows soft tissue opacity left  middle ear  with erosion of ear ossicles  and 
tegmen tympani. 
 
 
 
CT 
 
 T1 CORONAL 
 
 
T2 AXIAL 
 
 DWI 
 
 
ADC 
 
DISCUSSION 
Lesion appears heterointense in T1 and hyperintense in T2 and shows 
diffuse restriction with low ADC values - 0.59  x  10-3 mm2/s   and MRI 
findings consistent with  cholesteatoma. 
Postoperative  follow up found to be cholesteatoma . 
CASE 5 
A 15 year old girl comes with complaints of  left ear discharge with mild 
deafness past 4 months duration 
Patient was operated for cholesteatoma in left ear 1 year back 
Otoscopy reveals middle ear lesion highly suspicious of recurrence and 
referred for MRI. 
T1 AXIAL 
 
 
T2 AXIAL 
 
 
 
DWI 
 
 
 
 ADC 
 
DISCUSSION 
Lesion is T1 and T2 hyperintense and appears bright on diffusion images 
but doesnot shows significant low ADC values.  
Possibility of cholesteatoma based on high diffusion values  and  ADC 
values 0.41x  10-3 mm2/s   but Postoperative HPE reveals granulation 
tissue. 
 
 
 
CASE 6 
 
63 year old female patient comes with compliants of left ear discharge 7 
months. 
Mild hearing loss noted. 
Otoscopy  reveals nonspecific middle ear lesion. 
HRCT reveals middle ear soft tissue lesion . no evidence of  ossicular 
erosion. 
 
CT 
 
 
 T1 AXIAL 
 
 
T2 AXIAL 
 
 
T2 CORONAL 
 
 
DWI 
 
 
ADC 
 
 
 
DISCUSSION 
Lesion appears hyperintense on T1 ,T2 and FLAIR sequences and 
hypointense in DWI and hyperintense in ADC  sequences. ADC value is 
1.9  x  10-3 mm2/s   .Since no history of previous surgeries  diagnosis of 
cholesterol granuloma made out. 
Postsurgical HPE analysis confirms the diagnosis. 
 
 
 
CASE 7 
 
78 year old male  comes with compliants of right ear discharge past 1 
year. 
Mild hearing loss 8 months duration. 
Otoscopy reveals lesion in right mesotympanum. 
HRCT shows soft tissue mass in right middle ear  with erosion of scutum. 
T1 AXIAL 
 
 
 
 
T2 AXIAL 
 
 
DWI 
 
 
ADC 
 
 
 
DISCUSSION 
Lesion noted in the left middle ear  appearing hypointense on T1 images, 
hyperintense on T2  and FLAIR images  and showing diffusion restriction with 
corresponding low ADC values  - 0.75 x  10-3 mm2/s   and the provisional 
diagnosis of cholesteatoma was made . Patient was taken for surgery  and 
removal of middle ear mass done and specimen sent for histopathological 
analysis. 
HPE reveals and confirms the diagnosis of cholesteatoma. 
 
STASTICAL ANALYSIS 
               
   Table 1. Age group wise distribution of patients in the study 
Age group (years) N Percentage 
<20 8 20% 
20--29 14 35% 
30--39 8 20% 
40--49 4 10% 
50--59 6 15% 
Total 40 100% 
 
Fig. 1. Bar diagram shows age group wise comparison of patients in the study 
     
Cholesteatoma  affects all age groups  though it is common in middle age 
frequently. 
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 Table 2.  Proportion of gender in the study 
Sex N Percentage 
Male 19 48% 
Female 21 53% 
Total 40 100% 
 
 
 
 Fig. 2. Pie chart shows proportion of gender in the study 
                  
In cholesteatoma slight predominance  seen in females than males        
 
 
Male, 48%
Female, 53%
Proportion of gender in the study
Table 3. Status of previous surgery of patients in the study 
                     
Previous 
surgery 
N Percentage 
Present 12 30% 
Absent 28 70% 
Total 40 100% 
 
                  Fig. 3. Pie chart shows proportion of previous surgery of patients in  
the study 
 
 
               In our study  28 preoperative and 12 postoperative cases are included 
to prove the effeciency of DWI  in diagnosing cholesteatoma 
Present, 30%
Absent, 70%
Proportion of previous surgery 
               Table 4.Report of HRCT scan of patients in the study 
CT N Percentage 
Bone erosions positive suggestive of 
cholesteatoma 
29 72.5% 
Bone erosions negative and suspicious 
of cholesteatoma 
11 27.5% 
Total 40 100% 
 
 
 
Fig 4.Bar diagram shows Report of HRCT scan of patients in the study 
 
 
Bone erosions positive and
suggestive of cholesteatoma
Soft tissue without bone
erosions suspicious of
cholesteatoma
 Table 5. Diagnostic evaluation of  CT in pre and post operative cases with 
Histopathological report (HPE) 
 
CT (Pre+post operative) 
HPE 
Positive  
HPE 
Negative 
Total 
CT with bone erosion 27 1 28 
CT with out bone erosion 9 3 12 
Total 36 4 40 
 
CT: Computed Tomography 
HPE +ve: Confirmed  same as  cholesteatoma 
HPE -ve: Confirmed  same as  granulation tissue or cholesterol granuloma 
 
 
HRCT can diagnose cholesteatoma confidently if accompanied by bone or soft 
tissue erosions  and non specific if there is only soft tissue without 
accompanying bone erosions 
 
Table 6. 
Parameter 
CT (Pre+post  operative) 
Estimate 
Lower - Upper 95% 
CIs 
Sensitivity 75% (58.93, 86.25) 
Specificity 75% (30.06, 95.44) 
Positive Predictive Value 96.43% (82.29, 99.37) 
Negative Predictive Value 25% (8.894, 53.23) 
Diagnostic Accuracy 75% (59.81, 85.81) 
Method:Wilson Score 
 
Interpretation: In this study, Sensitivity was 75% with 95% confidence interval 
(58.93, 86.25) as well as Positive Predictive Value (PPV) showed an estimate 
96.43%  with 95% confidence interval (82.29, 99.37). It does mean that utility 
of CT  in diagnosing middle ear cholesteatomas was 75% sensitive to get HPE 
and its estimate for future studies would vary between 58.93 to  86.25. Here, 
Diagnostic accuracy of  CT was  also 75%. 
 
 
 
 DWI 
Table 7.DWI of patients in the study 
DWI N Percentage 
Restriction 37 93% 
Not restricted 3 8% 
Total 40 100% 
                                 
  
Fig 5.Pie chart shows  proportion of  DWI of patients 
 
Restriction, 93%
Not restricted, 
8%
DWI
Table 8. Diagnostic evaluation of  DWI with Histopathological report (HPE) 
DWI HPE Positive HPE Negative Total 
Restricted 36 1 37 
Not restricted 0 3 3 
Total 36 4 40 
DWI: Diffusion weighted image, 
HPE +ve: Confirmed  same as  cholesteatoma 
HPE -ve: Confirmed  same as  granulation tissue or cholesterol granuloma 
 
Table 9. 
Parameter 
DWI 
Estimate 
Lower - Upper 95% 
CIs 
Sensitivity 100% (90.36, 100 ) 
Specificity 75% (30.06, 95.44 ) 
Positive Predictive 
Value 
97.30% (86.18, 99.52 ) 
Negative Predictive 
Value 
100% (43.85, 100 ) 
Diagnostic Accuracy 97.5% (87.12, 99.56 ) 
Method:Wilson Score 
 
Interpretation: In this study, Sensitivity was 100% with 95% confidence interval 
(90.36, 100). as well as Positive Predictive Value (PPV) showed an estimate 
97.3%  with 95% confidence interval (86.18, 99.52). It does mean that utility of 
DWI in diagnosing middle ear cholesteatomas was 100% sensitive to get HPE 
and its estimate for future studies would vary between 90.36 to 100. Here, 
Diagnostic accuracy of DWI was  also higher (97.5%). 
 
Table 10. 
 Diagnostic evaluation of  DWI (preoperative cases) with Histopathological 
report (HPE) 
DWI in 
preoperative 
cases 
HPE Positive HPE Negative Total 
Restricted 27 0 27 
Not restricted 0 1 1 
Total 27 1 28 
 
DWI: Diffusion weighted image, 
HPE +ve: Confirmed  same as  cholesteatoma 
HPE -ve: Confirmed  same as  granulation tissue or cholesterol granuloma 
 Table 11 
Parameter 
 DWI in preoperative 
Estimate 
Lower - Upper 95% 
CIs 
Sensitivity 100% (87.54, 100 ) 
Specificity 100% (20.65, 100 ) 
Positive Predictive 
Value 
100% (87.54, 100 ) 
Negative Predictive 
Value 
100% (20.65, 100 ) 
Diagnostic Accuracy 100% (87.94, 100 ) 
Method:Wilson Score 
 
Interpretation: In this study, DWI for preoperative cases, Sensitivity, 
Specificity, PPV and NPV were the same (100%) with various confidence 
intervals  which show an  estimate for future studies would vary between 95% 
CI respectively. Here, Diagnostic accuracy of DWI was  also 100%. 
 
 
Table 12. Diagnostic evaluation of  DWI (postoperative cases)with 
Histopathological report (HPE) 
DWI 
(postoperative cases) 
HPE Positive 
HPE 
Negative 
Total 
Restricted 9 1 10 
Not restricted 0 2 2 
Total 9 3 12 
DWI: Diffusion weighted image, 
HPE +ve: Confirmed  same as  cholesteatoma 
HPE -ve: Confirmed  same as  granulation tissue or cholesterol granuloma 
 
Table 13 
Parameter 
(postoperative cases) 
Estimate 
Lower - Upper 
95% CIs 
Sensitivity 100% (70.08, 100) 
Specificity 66.67% (20.77, 93.85 ) 
Positive Predictive Value 90% (59.58, 98.21 ) 
Negative Predictive Value 100% (34.24, 100 ) 
Diagnostic Accuracy 91.67% (64.61, 98.51 ) 
Method:Wilson Score 
Interpretation: In this study, DWI for post operative cases, Sensitivity was 
100% and  PPV was 90% with confidence intervals  which show an  estimate 
for future studies would vary between 95% CI respectively. Here, Diagnostic 
accuracy of DWI was higher  91.67%. 
Table 14 ADC values of patients in the study 
ADC groups N Percentage 
<0.55 4 10% 
>=0.55 36 90% 
Total 40 100% 
 
Fig 6. Pie chart shows  status of patients with ADC values 
                      
 
Granulation tissue shows significantly  lower ADC values than cholesteatomas . 
most of cholesteatomas shows ADC values higher than 0.55 however infected 
cholesteatoma can show low ADC value. 
<0.55, 10%
>=0.55, 
90%
Proportion of ADC values 
Table 15  MRI report of patients in the study 
MRI N Percentage 
C 37 93% 
CG 1 3% 
GT 2 5% 
Total 40 100% 
 
C- Consistent with cholesteatoma, CG - Cholesterol granuloma, GT - 
Granulation Tissue 
Fig 7 Bar diagram compares MRI report of patients in the study 
 
C- Consistent with cholesteatoma, CG - Cholesterol granuloma, GT - 
Granulation Tissue 
                             In MRI we diagnosed 37 cases  as cholesteatoma and 1 case 
as cholesterol granuloma  and 2 cases as granulation tissue. 
0%
50%
100%
C CG GT
93%
3% 5%
MRI
Table 16. HPE of patients in the study 
HPE N Percentage 
H 36 93% 
HCG 1 3% 
HGT 3 5% 
Total 40 100% 
                                 
                                 H-HPE Confirmed  same as cholesteatoma, 
                                 HGT - Histopathology confirmed as granulation tissue, 
                                 HCG - Histopathology confirmed as cholesterol granuloma 
 
Fig 17 .HPE report of patients in the study 
 
   In our study  histopathology is used as gold standard against which our MRI 
findings are compared and analysed .  
                      In one case granulation tissue was  misdiagnosed as cholesteatoma 
0%
20%
40%
60%
80%
100%
H HCG HGT
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3% 5%
HPE report 
      
OBSERVATION AND DISCUSSION  
NEWLY DIAGNOSED CHOLESTEATOMA 
In Otoscopy-  pearly white mass and retracted tympanic membrane are usually  
seen. 
HRCT is  most useful to identify middle ear soft tissue and ossicular chain 
erosion and also erosions involving scutum and tegmen tympani. 
HRCT  also useful to identify extent of disease. 
MRI is useful to confirm the cholesteatoma . 
MRI is valuable in facial nerve and semicircular canal involvement. 
DWI has high sensitivity and specificity  in  the diagnosis of cholesteatoma. 
Diffusion restriction due to a combination  T2 shine through effect and 
diffusion effects.  
In our study out of 40 patients 28 cases are newly diagnosed cases of which 
MRI detects 27 cases accurately which confirmed post operatively. In one case 
it was found to be cholesterol granuloma which MRI detects accurately. In one 
case 12 year old male child  CT reveals minimal soft tissue density in middle 
ear and MRI doesnot  reveal any abnormality  so surgery is avoided and patient 
was diagnosed as otitis media and put on antibiotics and followup  and child 
clinically improved and repeat CT  after 1 month was normal. So this case is 
excluded  from  our study. 
 
POSTOPERATIVE EAR: 
Recurrent cholesteatoma  needs revision surgery  for eradication of underlying 
pathology . In case of granulation tissue usually supportive measures are needed 
and doesnot warrants revision surgery. 
Diffuse mucosal thickening of the middle ear with bony irregularities are 
difficult to evaluate with HRCT or MRI in postoperative cases . So revision 
surgery is usually done by surgeons to know the cause of  the soft tissue 
thickening. 
Otoscopy not very useful if there is opaque tympanic membrane and after 
cartilagenous reconstruction. 
CT can identify soft tissue mass but not able to differentiate between 
granulation tissue and cholesteatoma. 
CT is not useful  if there is no bone/ossicular erosion. 
Cholesteatoma shows diffusion restriction with low ADC values  whereas 
granulation tissue not shows diffusion restriction. 
Second look surgery can be avoided if there is no cholesteatoma. 
Our study confirms DWI has high sensitivity and specificity in diagnosing 
cholesteatoma and is confirmed with postoperative histopathological reports 
In our study out of 40 patients 12 are post operative cases  9 cases are diagnosed 
as cholesteatoma accurately and confirmed by postsurigical HPE analysis, three  
cases were diagnosed as granulation tissue . Out of   three granulation tissue two 
are picked up in the MRI accurately and one lesion is misdiagnosed as 
cholesteatoma which shows diffusion restriction  but with low ADC values 
compared to other cholesteatomas. 
MRI with DWI accurately diagnose all the cases of cholesteatoma in 
postoperative cases and has high sensitivity and specificity. 
Smallest lesion detected in our study is 4 mm. 
 
 
RESULTS 
From the study it is concluded that  DW MRI  has  100%  sensitivity, 75 % 
specificity , 97.3% PPV and  100% NPV in detecting cholesteatoma. Hence the 
MRI  is more accurate than  HRCT  in diagnosing  cholesteatomas. 
  
 
 
 
CONCLUSION 
ANNEXURES 
 
 
 
 
 
 
 
 
 
 CONCLUSION 
DWI is very useful in middle ear soft tissue evaluation.It can reliably detects all 
cases of primary cholesteatomas with sensitivity and specificity of 100% in our 
study. It can accurately distinguish granulation tissue, scar and cholesteatoma in 
postoperative  patients particularly when HRCT temporal bone found to be 
equivocal. Modern  non echoplanar diffusion techniques with thinner sections 
helps in the  detection of tiny lesions. These  techniques  has less incidence of 
susceptibility and ghost artifacts . DWI is primary used  following cartilaginous 
reconstruction or after canal wall up mastoidectomy when clinical examination 
is difficult . The DWI technique can replace the secondlook surgery, avoiding 
another surgical morbidity. It is as  efficient as post gadolinium enhanced scan 
and it has the advantage of non invasiveness and can be used in renal failure 
patients safely . DWI is superior to conventional T2  sequence  in detecting the 
cholesteatomas. HRCT and MRI are complementary to each other in diagnosing 
cholesteatomas. In preoperative cases HRCT  has high diagnostic accuracy and 
MRI is usually used to confirm the diagnosis  whereas in postoperative cases 
HRCT is highly non specific and  MRI  plays  significant role in diagnosing 
cholesteatomas. 
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